TY  - JOUR
AU  - Du, Yijia
AU  - Chu, Qian
AU  - Lou, Yanyan
AU  - He, Yong
AU  - Hu, Hongbo
AU  - Hu, Qipeng
AU  - Huang, Meijuan
TI  - Editorial: Immunotherapy for NSCLC with oncogenic driver variants.
JO  - Frontiers in oncology
VL  - 12
SN  - 2234-943X
CY  - Lausanne
PB  - Frontiers Media
M1  - DKFZ-2022-03208
SP  - 1095947
PY  - 2022
KW  - immune checkpoint inhibitors (Other)
KW  - lung cancer (Other)
KW  - oncogenic driver variants (Other)
KW  - targeted therapy resistance (Other)
KW  - tumor immune microenvironment (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:36568249
C2  - pmc:PMC9775290
DO  - DOI:10.3389/fonc.2022.1095947
UR  - https://inrepo02.dkfz.de/record/186487
ER  -